endoplasm
reticulum
er
major
histocompat
complex
mhc
class
molecul
load
epitop
caus
immun
cellular
respons
protein
antigen
degrad
cytoplasm
amino
acid
epitop
reach
er
antigen
target
organel
calreticulin
crt
fusion
avoid
degrad
enhanc
immun
respons
construct
recombin
adenoviru
express
antigen
ertarget
signal
peptid
sp
plu
er
retent
signal
kdel
sequenc
cellcultur
experi
demonstr
new
antigen
target
er
infect
mice
recombin
adenoviru
express
show
interferon
induct
tumourprotect
respons
similar
provid
adenoviru
express
antigen
fuse
crt
work
demonstr
ad
sp
kdel
sequenc
antigen
target
retain
er
consequ
enhanc
immun
respons
tumour
protect
result
signific
clinic
applic
mice
femal
mice
week
old
purchas
harlan
citi
hous
anim
facil
histolog
depart
school
medicin
uanl
care
conform
good
laboratori
practic
guidelin
cell
line
cell
maintain
advanc
dmem
supplement
heatinactiv
foetal
bovin
serum
fb
cell
deriv
primari
epitheli
cell
mice
cotransform
chara
oncogen
maintain
rpmi
medium
supplement
heatinactiv
fb
cell
line
purchas
american
type
cultur
collect
manassa
va
usa
adenoviru
purif
kit
cell
biolab
inc
san
diego
ca
usa
lyse
cell
mix
l
sd
load
buffer
heat
min
centrifug
rpm
min
protein
sampl
separ
electrophoresi
gel
transfer
nitrocellulos
membran
membran
block
hr
nonfat
dri
milk
tbst
mm
nacl
mm
kcl
mm
tri
hcl
tween
ph
probe
antibodi
tbst
hr
monoclon
antibodi
protein
zyme
use
probe
express
blot
rins
tbst
incub
rabbit
antimous
igghrp
second
antibodi
sigma
hr
rins
tbst
develop
super
signal
west
pico
stabl
peroxid
solut
pierc
cell
key
player
immun
respons
intracellular
infect
tumour
recognit
intracellular
viral
protein
cytotox
lymphocyt
requir
initi
cytosol
proteolyt
process
proteasom
peptid
product
transloc
transport
associ
antigen
process
tap
endoplasm
reticulum
er
assembl
major
histocompat
complex
mhc
class
molecul
present
cell
surfac
peptid
releas
proteasom
cytosol
promptli
degrad
cytosol
endopetidas
aminopeptidas
singl
amino
acid
escap
bind
tap
enter
er
calcul
one
peptid
bind
mhc
class
molecul
degrad
protein
explain
rel
subtl
effici
antigen
present
class
molecul
coupl
cervic
cancer
cell
well
number
malign
tumour
often
show
regul
subset
case
complet
loss
mhc
class
express
like
mechan
immun
escap
previou
studi
shown
antigen
link
calreticulin
crt
abund
kd
ca
bind
protein
locat
er
directli
express
er
avoid
cytoplasm
degrad
way
antigen
molecul
would
avail
degrad
er
larger
number
peptid
might
gener
load
onto
mhci
strategi
peptidespecif
tcell
respons
antigenantitumour
activ
murin
model
cervic
uterin
cancer
enhanc
fusion
human
papilloma
viru
herein
construct
adenoviru
express
antigen
sp
amino
end
kdel
sequenc
carboxyl
end
fig
distribut
er
immunofluoresc
stain
cell
infect
differ
adenovirus
use
antibodi
protein
calnexin
wellcharacter
marker
er
previou
studi
laboratori
other
demonstr
cytoplasmicnuclear
local
lost
fusion
calreticulin
sequest
er
shown
fig
previous
shown
fusion
crt
increas
five
time
releas
splenocyt
mice
immun
adenoviru
express
fusion
pgml
versu
adenoviru
express
pgml
increas
eight
time
versu
adenoviru
express
lacz
pgml
shown
fig
evalu
protect
effect
chimer
protein
murin
tumor
model
purpos
group
femal
adult
mice
challeng
murin
tumour
cell
design
week
immun
adenoviru
express
lacz
seen
fig
rapid
tumour
growth
observ
group
mice
immun
control
adenoviru
express
lacz
kill
expect
immun
adenoviru
express
protect
mice
tumour
develop
poor
immunogen
mice
kill
well
contrast
mice
vaccin
adenoviru
express
elimin
tumour
similar
protect
effect
demonstr
sp
kdel
signal
enough
enhanc
antitumour
immun
respons
taken
togeth
result
indic
adjuv
antitumour
effect
attribut
crt
mainli
confer
sp
kdel
sequenc
allow
antigen
enter
maintain
er
kdel
sequenc
emerg
signific
antitumour
immun
sequenc
recent
shown
dendrit
cell
load
exogen
peptid
bear
kdel
motif
show
effici
antitumour
activ
dendrit
cell
puls
peptid
without
kdel
even
though
mechan
epitop
gener
er
poorli
understood
kdel
sequenc
might
result
longer
traffick
time
er
increas
possibl
degrad
consequ
peptid
gener
load
molecul
worth
determin
contribut
sp
adjuv
effect
compar
addit
sp
kdel
sequenc
anoth
advantag
strategi
prevent
put
advers
effect
caus
overexpress
crt
exampl
role
ca
storag
transport
er
demonstr
fusion
crt
also
enhanc
humor
respons
antigen
receptorbind
domain
domain
iv
protect
antigen
pa
div
bacillu
anthraci
sar
coronaviru
antigen
even
though
pathway
unknown
expect
strategi
might
potenti
respons
well
conclus
target
antigen
er
confer
strike
immunogen
potenti
gene
cancer
therapi
work
repres
import
contribut
basic
research
futur
clinic
translat
